Galen Medical Group, P.C — Tennessee City, Tennessee

Galen Medical Group, P.C is a clinical research site located in Tennessee City, Tennessee, United States 37343.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Galen Medical Group, P.C has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Primary Biliary Cholangitis, PBC.

Sponsors: Mirum Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tennessee City

Browse all research sites in Tennessee · View every site in Tennessee City

• Vanderbilt University Medical Center
• Sarah Cannon Research Institute - Tennessee Oncology
• Allergy Associates, PA dba Allergy, Asthma and Sinus Center - Site Number: 840144
• KCA Neurology
• Tennessee Clinical Research Center
• Clinical Trial Site
• Dermata Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Galen Medical Group, P.C?

Galen Medical Group, P.C has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Galen Medical Group, P.C conducted?

Galen Medical Group, P.C has 1 clinical trials on record, with 1 currently active. Their work covers Primary Biliary Cholangitis, PBC.

Is Galen Medical Group, P.C accredited by Crixeo Clinical Trials?

Galen Medical Group, P.C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Galen Medical Group, P.C?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.